Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1993-05-10
1995-03-07
Rollins, John W.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 2712, 536 553, C07B 6300, C07H 2104, C07H 106
Patent
active
053959280
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
The invention relates generally to the preparation and/or analysis of synthetic phosphorothioate and -dithioate oligonucleotides, and more particularly, to a method for separating fully sulfurizing phosphorothioate or -dithioate oligonucleotides from incompletely sulfurized defect species by strong-anion exchange high performance liquid chromatography (HPLC).
BACKGROUND
Anti-sense oligonucleotides are being developed to treat a variety of diseases, particularly vital infections, e.g. Matsukura et al, Proc. Natl. Acad. Sci., Vol. 86, pgs. 4244-4448 (1989). An antisense oligonucleotide is a synthetic oligonucleotide of varying length, usually in the range of about 12 to 30 nucleotides, or nucleotide analogs, whose sequence is complementary to a predetermined segment of RNA, either freshly transcribed or messenger (mRNA), associated with some foreign or otherwise inappropriately expressed gene. It is believed that when an antisense oligonucleotide hybridizes to its target RNA, it either blocks translation or processing of the RNA or makes it susceptible to enzymatic degradation. One problem with this approach has been the difficulty of getting the antisense oligonucleotide to its target RNA in sufficient concentration and for sufficient duration to be effective in shutting down the synthesis of undesired proteins, e.g. viral enzymes, coat proteins, and the like. The susceptibility of the phosphodiester linkage of the oligonucleotides to nuclease digestion is believed to be an important cause of this difficulty, and has prompted the development of a variety of nucleoside oligomers linked by nuclease-resistant analogs of the natural phosphodiester bond, e.g. Miller et al, U.S. Pat. No. 4,511,713 and Ts'o U.S. Pat. No. 4,469,863 (methyl- and arylphosphonates); Miro et al, Nucleic Acids Research, Vol. 17, pgs. 8207-8219 (1989) (phosphoroselenoates); Brill et al, J. Am. Chem. Soc., Vol. 111, pg. 2321 (1989) (phosphorodithioates); and Matsukura et al, Proc. Natl. Acad. Sci., Vol. 84, pgs. 7706-7710 (1987), and Gene, Vol. 72, pgs. 343-347 (1988) (phosphorothioates).
The phosphorothioate and phosphorodithioate analogs are especially promising because they are highly nuclease-resistant, have the same charge as natural oligonucleotides, and are taken up by cells in effective amounts.
Phosphorothioates can be synthesized by automated DNA synthesizers using hydrogen phosphonate or phosphoramidite chemistries. In the former approach, the phosphonate backbone can be sulfurized in a single step off of the automated synthesizer after synthesis. This is advantageous because the phosphonate moieties are sulfurized by exposure to elemental sulfur dissolved in an organic solvent. Since the sulfur readily precipitates out of solution, the off-column sulfurization avoids costly blockages of valves and tubing of the synthesizer by sulfur precipitates. A drawback of of this route of phosphorothioate synthesis is that coupling yields during chain elongation are typically lower than those obtained using phosphoramidite chemistry, Gaffney and Jones, Tett. Lett., Vol. 29, pgs. 2619-2622 (1988). The practical importance of high coupling yields is demonstrated by the synthesis of a 28-mer where a 99% coupling yield per step results in an overall yield of 76% (0.99.sup.27), whereas a 96% yield per step results in an overall yield of only 33% (0.96.sup.27).
Phosphoramidite chemistry, with coupling yields typically greater than 99%, is presently the more desirable approach to phosphorothioate and phosphorodithioate synthesis. However, the phosphite intermediates, which would be sulfurized, are unstable under the conditions of the detritylization step of the reaction cycle. Thus, the phosphite linkage must be sulfurized after each coupling step. This can be accomplished with a variety of sulfurizing agents, e.g. Matsukura et al, Gene (cited above)(elemental sulfur); lyer et al, J. Org. Chem., Vol. 55, pgs. 4693-4699 (1990)(a thiosulfonate sulfurizing agent); Hirschbein, PCT application US91/01008 (thiuram disulfide
REFERENCES:
patent: 5183885 (1993-02-01), Bergot
La Planche et al. Nucl. Acids. Res. 14: 9081-9093, 1986.
Pearson, J. J. Amer. Chem. Soc. 85: 3533-3539, 1963.
Matsukura et al. Proc. Natl. Acad. Sci 84: 7706-7710, 1987.
Chemical Abstracts 112(11): 94794t, Maisano et al. Bio-Chromatography 4(5): 279-281, 1989.
Kunz Gary L.
Lynx Therapeutics, Inc.
Rollins John W.
LandOfFree
Chromatographic separation of phosphorothioate oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chromatographic separation of phosphorothioate oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromatographic separation of phosphorothioate oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1406894